• Mashup Score: 1
    Why I . . . am involved in musical theatre - 1 year(s) ago

    Consultant oncologist Alison Birtle talks to Helen Jones about her love of performing and how it is helping her recovery from serious complications of covid “I had already decided at the age of four that I wanted to be a doctor, but music and performing are a big part of my life,” says consultant oncologist Alison Birtle. While at medical school in London she performed in Grease , Cabaret , and…

    Source: The BMJ
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of AlisonBirtle
      AlisonBirtle

      RT @pash22: Why I . . . am involved in musical theatre https://t.co/q5iuh665Ay @AlisonBirtle talks to @bmj_latest 's #HelenJones

  • Mashup Score: 3
    Stanford Cancer Institute Breakthroughs in Cancer: Charles Sawyers, MD - 1 year(s) ago

    Topic: Prostate Cancer Initiation and PlasticityMemorial Sloan Kettering physician-scientist Charles Sawyers, MD, specializes in new drug development for leu…

    Source: YouTube
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of SCIDirector
      SCIDirector

      I had the pleasure of hosting Charles Sawyers from @MSKCancerCenter as our distinguished guest at our monthly Breakthroughs in Cancer seminar. Watch: https://t.co/EiZfCxZSL1. #prostatecancer Save the date for our 9/12 seminar with Ursula Matulonis of @DanaFarber #OvarianCancer

  • Mashup Score: 1
    BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas - PubMed - 1 year(s) ago

    In this small, single-group study involving patients with papillary craniopharyngiomas, 15 of 16 patients had a partial response or better to the BRAF-MEK inhibitor combination vemurafenib-cobimetinib. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT03224767.).

    Source: PubMed
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of christine_lovly
      christine_lovly

      #PrecisionMedicine for a rare brain cancer: Papillary craniopharyngiomas. ➡️>90% have BRAF V600E ➡️94% ORR to anti-BRAF-MEK therapy (n=16 pts) Impressive! @NEJM @OncoAlert BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas https://t.co/5kJbM6tO8p

  • Mashup Score: 0
    Join our Cloud HD Video Meeting - 1 year(s) ago

    Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…

    Source: Zoom Video
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of christine_lovly
      christine_lovly

      ➡️ Happening now! @VUMC_Medicine grand rounds: @CathyEngMD presents “The Enigma of Early Onset #Colorectal #Cancer”. In person + livestream: https://t.co/uSIlr3F76w Dr. Eng is a leading expert on this important public health topic! @OncoAlert @VUMC_Cancer @VUMChealth https://t.co/zP0xnFzwlU

  • Mashup Score: 0
    Nomination Committee Elections 2023 - 1 year(s) ago

    ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.

    Source: www.esmo.org
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of TeresaSAmaral
      TeresaSAmaral

      If you are an @myESMO #member you have now the chance to choose #ESMO Nomination #Committee The Electronic Ballot Vote is Now Open 📥 You can find out more about the candidates & view their documentation here → https://t.co/dnIvoBsuO9

Load More